GlassScriptPhysician profile
Anna G Hanson
NPI 1407238066
$792.72
in general payments reported to CMS, 2019-2025
17 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $47.09 · 2021: $15.78 · 2022: $21.85 · 2023: $347 · 2024: $242 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.38 | 2023-2025 | |
| Novo Nordisk INC | $86.47 | 2020-2024 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $77.63 | 2023-2025 | Otezla, Repatha, Tavneos |
| Lilly USA, LLC | $67.27 | 2020-2024 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $50.52 | 2023 | Veozah |
| Boston Scientific Corporation | $50.29 | 2024 | Wavewriter Alpha Prime 16, Watchman Flx |
| Abbott Laboratories | $43.17 | 2023-2025 | Freestyle Libre 3 |
| Organon LLC | $36.85 | 2023 | Nexplanon |
| E.R. Squibb & Sons, L.L.C. | $29.54 | 2023 | Eliquis |
| Averitas Pharma INC. | $26.87 | 2023 | Qutenza |
| Cequr Corporation | $26.02 | 2023 | Cequr Simplicity |
| Biohaven Pharmaceutical Holding Company LTD. | $21.85 | 2022 | |
| Recor Medical INC | $21.78 | 2025 | Paradise Ultrasound Renal Denervation System |
| Glaxosmithkline, LLC. | $18.39 | 2023 | Shingrix, Bexsero, Arexvy |
| Merck Sharp & Dohme LLC | $17.36 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15.43 | 2024 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $14.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.